PT  - JOURNAL ARTICLE
AU  - Ely A. Wolin
AU  - Kevin P. Banks
AU  - Penny J. Vroman
TI  - Bisphosphonate-Associated Atypical Subtrochanteric Femur Fracture
AID  - 10.2967/jnmt.114.139923
DP  - 2015 Mar 01
TA  - Journal of Nuclear Medicine Technology
PG  - 72--73
VI  - 43
IP  - 1
4099  - http://tech.snmjournals.org/content/43/1/72.short
4100  - http://tech.snmjournals.org/content/43/1/72.full
SO  - J. Nucl. Med. Technol.2015 Mar 01; 43
AB  - Bisphosphonates help prevent progressive bone mineralization loss and subsequent osteoporotic fractures. However, long-term bisphosphonate therapy paradoxically increases the risk of a unique injury called an atypical subtrochanteric femur fracture. Despite this, the benefits of bisphosphonates outweigh the risks, because far more pathologic fractures are prevented than induced. The early identification of atypical subtrochanteric femur fractures is important as there is high associated morbidity and mortality. We describe a case of a 76-y-old woman with a completed bisphosphonate-associated atypical subtrochanteric femur fracture.